Choice of ventricular arrhythmia therapy in coronary artery disease

Aim. To study trigger factors of ventricular arrhythmias (VA) in patients with stable coronary artery disease (CAD) and evaluate the effectiveness of individualized treatment.Material and methods. The study included 155 patients with CAD aged 36 to 83 years (61,5±9,8 years); 73,5% were men with freq...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Tatarinova, E. A. Ryngach, T. V. Treshkur
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2020-08-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/3707
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850030880248037376
author A. A. Tatarinova
E. A. Ryngach
T. V. Treshkur
author_facet A. A. Tatarinova
E. A. Ryngach
T. V. Treshkur
author_sort A. A. Tatarinova
collection DOAJ
description Aim. To study trigger factors of ventricular arrhythmias (VA) in patients with stable coronary artery disease (CAD) and evaluate the effectiveness of individualized treatment.Material and methods. The study included 155 patients with CAD aged 36 to 83 years (61,5±9,8 years); 73,5% were men with frequent single and coupled ventricular ectopic complexes (VEC) and the left ventricle ejection fraction (LVEF) of 56,4±8,5%. Exclusion criteria were class IV angina, acute coronary syndrome, LV aneurysm, LVEF ≤45%. Treatment and examination of patients was carried out according to the algorithm we proposed in 2017 for managing patients with CAD and high-grade VA.Results. Depending on association between ventricular ectopy and transient myocardial ischemia (TMI) during an exercise tolerance test, patients were divided into 2 groups. Group I included 84 patients (54,2%) with ischemic VA. According to noninvasive topical diagnostics, the arrhythmogenic focus in all patients with ischemic VA was located in the left ventricle. Group II consisted of 71 (45,8%) patients with nonischemic VA, and two subgroups were distinguished depending on presence/absence of TMI: 2A and 2B. During the exercise test, several types of VA were identified.Myocardial revascularization (MR) was indicated in 84,5% of cases in both groups. Six months after MR in group I, the antiarrhythmic effect (AAE) was observed in 55 (77,5%) patients. In group IIA, AAE was significantly lower at 61,7% (p=0,048). We also revealed anxiety in 15 patients of group II. Anxiolytic therapy showed AAE in 75% of group IIA patients and in 63,6% of group IIB patients. Nine patients of group II were referred to radiofrequency ablation of VA with a positive effect of 55,5%. Antiarrhythmic drugs (amiodarone, sotalol) were taken by 5 people of group I.Conclusion. The search for trigger factors and their elimination provides a high AAE for VA therapy in patients with CAD.
format Article
id doaj-art-148b1848df894861ba62e1430b787c4d
institution DOAJ
issn 1560-4071
2618-7620
language Russian
publishDate 2020-08-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-148b1848df894861ba62e1430b787c4d2025-08-20T02:59:07Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202020-08-0125710.15829/1560-4071-2020-37072889Choice of ventricular arrhythmia therapy in coronary artery diseaseA. A. Tatarinova0E. A. Ryngach1T. V. Treshkur2Almazov National Medical Research CenterAlmazov National Medical Research CenterAlmazov National Medical Research CenterAim. To study trigger factors of ventricular arrhythmias (VA) in patients with stable coronary artery disease (CAD) and evaluate the effectiveness of individualized treatment.Material and methods. The study included 155 patients with CAD aged 36 to 83 years (61,5±9,8 years); 73,5% were men with frequent single and coupled ventricular ectopic complexes (VEC) and the left ventricle ejection fraction (LVEF) of 56,4±8,5%. Exclusion criteria were class IV angina, acute coronary syndrome, LV aneurysm, LVEF ≤45%. Treatment and examination of patients was carried out according to the algorithm we proposed in 2017 for managing patients with CAD and high-grade VA.Results. Depending on association between ventricular ectopy and transient myocardial ischemia (TMI) during an exercise tolerance test, patients were divided into 2 groups. Group I included 84 patients (54,2%) with ischemic VA. According to noninvasive topical diagnostics, the arrhythmogenic focus in all patients with ischemic VA was located in the left ventricle. Group II consisted of 71 (45,8%) patients with nonischemic VA, and two subgroups were distinguished depending on presence/absence of TMI: 2A and 2B. During the exercise test, several types of VA were identified.Myocardial revascularization (MR) was indicated in 84,5% of cases in both groups. Six months after MR in group I, the antiarrhythmic effect (AAE) was observed in 55 (77,5%) patients. In group IIA, AAE was significantly lower at 61,7% (p=0,048). We also revealed anxiety in 15 patients of group II. Anxiolytic therapy showed AAE in 75% of group IIA patients and in 63,6% of group IIB patients. Nine patients of group II were referred to radiofrequency ablation of VA with a positive effect of 55,5%. Antiarrhythmic drugs (amiodarone, sotalol) were taken by 5 people of group I.Conclusion. The search for trigger factors and their elimination provides a high AAE for VA therapy in patients with CAD.https://russjcardiol.elpub.ru/jour/article/view/3707ventricular arrhythmiasischemiaexercise tolerance testantiarrhythmic effectmyocardial revascularization
spellingShingle A. A. Tatarinova
E. A. Ryngach
T. V. Treshkur
Choice of ventricular arrhythmia therapy in coronary artery disease
Российский кардиологический журнал
ventricular arrhythmias
ischemia
exercise tolerance test
antiarrhythmic effect
myocardial revascularization
title Choice of ventricular arrhythmia therapy in coronary artery disease
title_full Choice of ventricular arrhythmia therapy in coronary artery disease
title_fullStr Choice of ventricular arrhythmia therapy in coronary artery disease
title_full_unstemmed Choice of ventricular arrhythmia therapy in coronary artery disease
title_short Choice of ventricular arrhythmia therapy in coronary artery disease
title_sort choice of ventricular arrhythmia therapy in coronary artery disease
topic ventricular arrhythmias
ischemia
exercise tolerance test
antiarrhythmic effect
myocardial revascularization
url https://russjcardiol.elpub.ru/jour/article/view/3707
work_keys_str_mv AT aatatarinova choiceofventriculararrhythmiatherapyincoronaryarterydisease
AT earyngach choiceofventriculararrhythmiatherapyincoronaryarterydisease
AT tvtreshkur choiceofventriculararrhythmiatherapyincoronaryarterydisease